Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+11.3%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| 1 |
Tesla
TSLA
|
+$125M |
| 2 |
Home Depot
HD
|
+$110M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
IS
ironSource Ltd.
IS
|
+$107M |
| 5 |
Pfizer
PFE
|
+$105M |
Top Sells
| 1 |
AT&T
T
|
+$246M |
| 2 |
Intel
INTC
|
+$218M |
| 3 |
Ford
F
|
+$164M |
| 4 |
Micron Technology
MU
|
+$149M |
| 5 |
General Motors
GM
|
+$144M |
Sector Composition
| 1 | Technology | 25.17% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.2% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Surmodics
SRDX
$471M
| $287K | ﹤0.01% |
5,970
-5,630
| -49% | -$271K |
|
1827
uniQure
QURE
$960M
| $286K | ﹤0.01% |
13,800
| – | – |
|
1828
James River Group
JRVR
$242M
| $285K | ﹤0.01% |
9,900
| – | – |
|
1829
Blink Charging
BLNK
$130M
| $283K | ﹤0.01% |
+10,680
| New | +$283K |
|
1830
California Resources
CRC
$4.14B
| $283K | ﹤0.01% |
+6,630
| New | +$283K |
|
1831
National Bank Holdings
NBHC
$1.5B
| $283K | ﹤0.01% |
6,440
-4,860
| -43% | -$214K |
|
|
ATYR
1832
aTyr Pharma
ATYR
$520M
| $283K | ﹤0.01% |
37,884
| – | – |
|
1833
Atara Biotherapeutics
ATRA
$85.5M
| $282K | ﹤0.01% |
717
-2,032
| -74% | -$799K |
|
1834
nCino
NCNO
$3.52B
| $282K | ﹤0.01% |
+5,140
| New | +$282K |
|
1835
Revolution Medicines
RVMD
$7.65B
| $281K | ﹤0.01% |
+11,150
| New | +$281K |
|
1836
Allogene Therapeutics
ALLO
$253M
| $280K | ﹤0.01% |
+18,790
| New | +$280K |
|
1837
Heidrick & Struggles
HSII
$1.04B
| $280K | ﹤0.01% |
6,400
| – | – |
|
1838
Karyopharm Therapeutics
KPTI
$54.9M
| $279K | ﹤0.01% |
+2,892
| New | +$279K |
|
1839
Magnite
MGNI
$3.47B
| $274K | ﹤0.01% |
+15,630
| New | +$274K |
|
1840
Theravance Biopharma
TBPH
$701M
| $274K | ﹤0.01% |
+24,830
| New | +$274K |
|
|
WLL
1841
DELISTED
Whiting Petroleum Corporation
WLL
| $272K | ﹤0.01% |
+4,200
| New | +$272K |
|
1842
FibroGen
FGEN
$46.4M
| $271K | ﹤0.01% |
+768
| New | +$271K |
|
1843
SelectQuote
SLQT
$351M
| $271K | ﹤0.01% |
29,920
-30,580
| -51% | -$277K |
|
1844
First Commonwealth Financial
FCF
$1.86B
| $269K | ﹤0.01% |
16,700
| – | – |
|
1845
Houlihan Lokey
HLI
$14B
| $269K | ﹤0.01% |
+2,595
| New | +$269K |
|
1846
Kratos Defense & Security Solutions
KTOS
$10.9B
| $269K | ﹤0.01% |
+13,850
| New | +$269K |
|
1847
Vipshop
VIPS
$8.72B
| $269K | ﹤0.01% |
32,000
| – | – |
|
|
CMPI
1848
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $268K | ﹤0.01% |
93,334
-26,581
| -22% | -$76.3K |
|
1849
Pennant Group
PNTG
$847M
| $267K | ﹤0.01% |
11,582
-12,570
| -52% | -$290K |
|
1850
Atea Pharmaceuticals
AVIR
$258M
| $266K | ﹤0.01% |
+29,780
| New | +$266K |
|